Neuropsychopharmacology
Fleischhacker, W. W.
ISBN 10: 321183902X ISBN 13: 9783211839027
Edité par Springer, 2003
Neuf(s)
Couverture souple
Vendeur
GreatBookPrices, Columbia, MD, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Vendeur AbeBooks depuis 6 avril 2009
Cet article spécifique n'est plus disponible.
A propos de cet article
Description :
N° de réf. du vendeur 6907495-n
Synopsis :
The 5th Neuropsychiatry Symposium of the European Institute of Health- care was devoted to neuropsychopharmacology. As in previous meetings, we sought to choose topics that bridge the gap between basic neuroscience and the clinical fields of neurology and psychiatry. Consequently, the pro- ceedings published in this supplement cover a lot of ground. Late breaking data on various neuromodulator and neurotransmitter systems and their implications for the treatment of a number of disorders are reviewed. Jean- Charles Schwartz and colleagues set the stage with their paper on constitu- tive receptor activity, using the histamine H3-receptor to illustrate the point. The role of neuropeptides and neurotrophins in psychiatric disorders is then reviewed by Florian Holsboer, while Bill Deakin elucidates the role of sero- tonin, discovered 50 years ago in the brain, in select psychiatric syndromes. New pharmacological developments in the treatment of migraine, Parkin- son's disease and schizophrenia are then presented by Hans Christoph Diener, Eduardo Tolosa and Wolfgang Fleischhacker. In the end David Nutt and colleagues provide future directions in substance dependence research, linking the role of various transmitter systems with findings from neu- roimaging studies. In summary, there is no doubt that progress in the field of neuropsychopharmacology is exciting and the prospects of true advances in the treatment of brain disorders are very promising.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Détails bibliographiques
Titre : Neuropsychopharmacology
Éditeur : Springer
Date d'édition : 2003
Reliure : Couverture souple
Etat : New
Meilleurs résultats de recherche sur AbeBooks
Image fournie par le vendeur
Neuropsychopharmacology
impression à la demandeVendeur : moluna, Greven, Allemagne
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 receptor (J.-C. Schwartz, S. Morisset, A. Rouleau, X. Ligneau, F. Gbahou, J. Tardivel-Lacombe, H. Stark, W. Schunack, C. R. Ganellin and J. M. Arrang) The role o. N° de réf. du vendeur 4489268
Quantité disponible : Plus de 20 disponibles
Image d'archives
Neuropsychopharmacology (Journal of Neural Transmission. Supplementa, 64)
Vendeur : Lucky's Textbooks, Dallas, TX, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. N° de réf. du vendeur ABLIING23Mar3113020085456
Quantité disponible : Plus de 20 disponibles
Image d'archives
Neuropsychopharmacology (Paperback)
Edité par
Springer Verlag GmbH, Vienna, 2003
ISBN 10 : 321183902X
ISBN 13 : 9783211839027
Neuf
Paperback
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Paperback. Etat : new. Paperback. The 5th Neuropsychiatry Symposium of the European Institute of Health- care was devoted to neuropsychopharmacology. As in previous meetings, we sought to choose topics that bridge the gap between basic neuroscience and the clinical fields of neurology and psychiatry. Consequently, the pro- ceedings published in this supplement cover a lot of ground. Late breaking data on various neuromodulator and neurotransmitter systems and their implications for the treatment of a number of disorders are reviewed. Jean- Charles Schwartz and colleagues set the stage with their paper on constitu- tive receptor activity, using the histamine H3-receptor to illustrate the point. The role of neuropeptides and neurotrophins in psychiatric disorders is then reviewed by Florian Holsboer, while Bill Deakin elucidates the role of sero- tonin, discovered 50 years ago in the brain, in select psychiatric syndromes. New pharmacological developments in the treatment of migraine, Parkin- son's disease and schizophrenia are then presented by Hans Christoph Diener, Eduardo Tolosa and Wolfgang Fleischhacker.In the end David Nutt and colleagues provide future directions in substance dependence research, linking the role of various transmitter systems with findings from neu- roimaging studies. In summary, there is no doubt that progress in the field of neuropsychopharmacology is exciting and the prospects of true advances in the treatment of brain disorders are very promising. The 5th Neuropsychiatry Symposium of the European Institute of HealthA care was devoted to neuropsychopharmacology. As in previous meetings, we sought to choose topics that bridge the gap between basic neuroscience and the clinical fields of neurology and psychiatry. Consequently, the proA ceedings published in this supplement cover a lot of ground. Late breaking data on various neuromodulator and neurotransmitter systems and their implications for the treatment of a number of disorders are reviewed. JeanA Charles Schwartz and colleagues set the stage with their paper on constituA tive receptor activity, using the histamine H3-receptor to illustrate the point. The role of neuropeptides and neurotrophins in psychiatric disorders is then reviewed by Florian Holsboer, while Bill Deakin elucidates the role of seroA tonin, discovered 50 years ago in the brain, in select psychiatric syndromes. New pharmacological developments in the treatment of migraine, ParkinA son's disease and schizophrenia are then presented by Hans Christoph Diener, Eduardo Tolosa and Wolfgang Fleischhacker. In the end David Nutt and colleagues provide future directions in substance dependence research, linking the role of various transmitter systems with findings from neuA roimaging studies. In summary, there is no doubt that progress in the field of neuropsychopharmacology is exciting and the prospects of true advances in the treatment of brain disorders are very pro Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9783211839027
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Neuropsychopharmacology
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - The 5th Neuropsychiatry Symposium of the European Institute of Health care was devoted to neuropsychopharmacology. As in previous meetings, we sought to choose topics that bridge the gap between basic neuroscience and the clinical fields of neurology and psychiatry. Consequently, the pro ceedings published in this supplement cover a lot of ground. Late breaking data on various neuromodulator and neurotransmitter systems and their implications for the treatment of a number of disorders are reviewed. Jean Charles Schwartz and colleagues set the stage with their paper on constitu tive receptor activity, using the histamine H3-receptor to illustrate the point. The role of neuropeptides and neurotrophins in psychiatric disorders is then reviewed by Florian Holsboer, while Bill Deakin elucidates the role of sero tonin, discovered 50 years ago in the brain, in select psychiatric syndromes. New pharmacological developments in the treatment of migraine, Parkin son's disease and schizophrenia are then presented by Hans Christoph Diener, Eduardo Tolosa and Wolfgang Fleischhacker. In the end David Nutt and colleagues provide future directions in substance dependence research, linking the role of various transmitter systems with findings from neu roimaging studies. In summary, there is no doubt that progress in the field of neuropsychopharmacology is exciting and the prospects of true advances in the treatment of brain disorders are very promising. N° de réf. du vendeur 9783211839027
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Neuropsychopharmacology
Edité par
Springer Vienna, Springer Vienna Mai 2003, 2003
ISBN 10 : 321183902X
ISBN 13 : 9783211839027
Neuf
Taschenbuch
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The 5th Neuropsychiatry Symposium of the European Institute of Health care was devoted to neuropsychopharmacology. As in previous meetings, we sought to choose topics that bridge the gap between basic neuroscience and the clinical fields of neurology and psychiatry. Consequently, the pro ceedings published in this supplement cover a lot of ground. Late breaking data on various neuromodulator and neurotransmitter systems and their implications for the treatment of a number of disorders are reviewed. Jean Charles Schwartz and colleagues set the stage with their paper on constitu tive receptor activity, using the histamine H3-receptor to illustrate the point. The role of neuropeptides and neurotrophins in psychiatric disorders is then reviewed by Florian Holsboer, while Bill Deakin elucidates the role of sero tonin, discovered 50 years ago in the brain, in select psychiatric syndromes. New pharmacological developments in the treatment of migraine, Parkin son's disease and schizophrenia are then presented by Hans Christoph Diener, Eduardo Tolosa and Wolfgang Fleischhacker. In the end David Nutt and colleagues provide future directions in substance dependence research, linking the role of various transmitter systems with findings from neu roimaging studies. In summary, there is no doubt that progress in the field of neuropsychopharmacology is exciting and the prospects of true advances in the treatment of brain disorders are very promising. 128 pp. Englisch. N° de réf. du vendeur 9783211839027
Quantité disponible : 1 disponible(s)
Image d'archives
Neuropsychopharmacology (Journal of Neural Transmission. Supplementa, 64)
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. In. N° de réf. du vendeur ria9783211839027_new
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Neuropsychopharmacology
Edité par
Springer Vienna Mai 2003, 2003
ISBN 10 : 321183902X
ISBN 13 : 9783211839027
Neuf
Taschenbuch
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The 5th Neuropsychiatry Symposium of the European Institute of Health care was devoted to neuropsychopharmacology. As in previous meetings, we sought to choose topics that bridge the gap between basic neuroscience and the clinical fields of neurology and psychiatry. Consequently, the pro ceedings published in this supplement cover a lot of ground. Late breaking data on various neuromodulator and neurotransmitter systems and their implications for the treatment of a number of disorders are reviewed. Jean Charles Schwartz and colleagues set the stage with their paper on constitu tive receptor activity, using the histamine H3-receptor to illustrate the point. The role of neuropeptides and neurotrophins in psychiatric disorders is then reviewed by Florian Holsboer, while Bill Deakin elucidates the role of sero tonin, discovered 50 years ago in the brain, in select psychiatric syndromes. New pharmacological developments in the treatment of migraine, Parkin son's disease and schizophrenia are then presented by Hans Christoph Diener, Eduardo Tolosa and Wolfgang Fleischhacker. In the end David Nutt and colleagues provide future directions in substance dependence research, linking the role of various transmitter systems with findings from neu roimaging studies. In summary, there is no doubt that progress in the field of neuropsychopharmacology is exciting and the prospects of true advances in the treatment of brain disorders are very promising. 128 pp. Englisch. N° de réf. du vendeur 9783211839027
Quantité disponible : 2 disponible(s)
Image d'archives
Neuropsychopharmacology (Journal of Neural Transmission. Supplementa)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Paperback. Etat : Brand New. 1st edition. 117 pages. 10.80x8.30x0.20 inches. In Stock. N° de réf. du vendeur x-321183902X
Quantité disponible : 2 disponible(s)
Image d'archives
Neuropsychopharmacology (Paperback)
Edité par
Springer Verlag GmbH, Vienna, 2003
ISBN 10 : 321183902X
ISBN 13 : 9783211839027
Neuf
Paperback
Vendeur : AussieBookSeller, Truganina, VIC, Australie
Évaluation du vendeur 5 sur 5 étoiles
Paperback. Etat : new. Paperback. The 5th Neuropsychiatry Symposium of the European Institute of Health- care was devoted to neuropsychopharmacology. As in previous meetings, we sought to choose topics that bridge the gap between basic neuroscience and the clinical fields of neurology and psychiatry. Consequently, the pro- ceedings published in this supplement cover a lot of ground. Late breaking data on various neuromodulator and neurotransmitter systems and their implications for the treatment of a number of disorders are reviewed. Jean- Charles Schwartz and colleagues set the stage with their paper on constitu- tive receptor activity, using the histamine H3-receptor to illustrate the point. The role of neuropeptides and neurotrophins in psychiatric disorders is then reviewed by Florian Holsboer, while Bill Deakin elucidates the role of sero- tonin, discovered 50 years ago in the brain, in select psychiatric syndromes. New pharmacological developments in the treatment of migraine, Parkin- son's disease and schizophrenia are then presented by Hans Christoph Diener, Eduardo Tolosa and Wolfgang Fleischhacker.In the end David Nutt and colleagues provide future directions in substance dependence research, linking the role of various transmitter systems with findings from neu- roimaging studies. In summary, there is no doubt that progress in the field of neuropsychopharmacology is exciting and the prospects of true advances in the treatment of brain disorders are very promising. The 5th Neuropsychiatry Symposium of the European Institute of HealthA care was devoted to neuropsychopharmacology. As in previous meetings, we sought to choose topics that bridge the gap between basic neuroscience and the clinical fields of neurology and psychiatry. Consequently, the proA ceedings published in this supplement cover a lot of ground. Late breaking data on various neuromodulator and neurotransmitter systems and their implications for the treatment of a number of disorders are reviewed. JeanA Charles Schwartz and colleagues set the stage with their paper on constituA tive receptor activity, using the histamine H3-receptor to illustrate the point. The role of neuropeptides and neurotrophins in psychiatric disorders is then reviewed by Florian Holsboer, while Bill Deakin elucidates the role of seroA tonin, discovered 50 years ago in the brain, in select psychiatric syndromes. New pharmacological developments in the treatment of migraine, ParkinA son's disease and schizophrenia are then presented by Hans Christoph Diener, Eduardo Tolosa and Wolfgang Fleischhacker. In the end David Nutt and colleagues provide future directions in substance dependence research, linking the role of various transmitter systems with findings from neuA roimaging studies. In summary, there is no doubt that progress in the field of neuropsychopharmacology is exciting and the prospects of true advances in the treatment of brain disorders are very pro Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. N° de réf. du vendeur 9783211839027
Quantité disponible : 1 disponible(s)